Evidence map›Paper›PMID 35441491›Full record

ArticleESC heart failure2022

The trajectory of renal function following mechanical circulatory support and subsequent heart transplantation.

Sven-Erik Bartfay, Oscar Kolsrud, Peter Wessman, Göran Dellgren, Kristjan Karason

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Kidney health and function with left ventricular assist devices.Current opinion in nephrology and hypertension · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sven-Erik BartfayDepartment of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID 0000-0002-8490-6154
Oscar KolsrudDepartment of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Peter WessmanCentre of Registers Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Göran DellgrenInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Kristjan KarasonInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Sahlgrenska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimPatients with advanced heart failure (HF) frequently suffer from renal insufficiency. The impact of durable mechanical circulatory support (MCS) and subsequent heart transplantation (HTx) on kidney function is not well described. METHODS AND

resultsWe studied patients with advanced HF who received durable MCS as bridge to transplantation (BTT) and underwent subsequent HTx at our centre between 1996 and 2018. Glomerular filtration rate (GFR) was measured by

conclusionsIn patients with advanced heart failure, measured GFR improved after MCS with no difference between pulsatile and CF-pumps. The total study group showed no further increase in GFR following HTx, but in certain subgroups, including patients aged 35-54 years and those treated during the latest era (2012-2018), renal function appeared to improve after transplant.

Indexed as

Heart-Assist DevicesHeart FailureHeart TransplantationFemaleHumansKidneyMaleRetrospective StudiesAdvanced heart failureBiventricular assist device (BiVAD)Cardiorenal syndromeGlomerular filtration rateLeft ventricular assist device (LVAD)Mechanical circulatory support

Identifiers

PMID35441491
PMCPMC9288773
OpenAlexW4224255344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.